Regionalization of congenital heart surgery centers has the potential to improve quality of care and outcomes while potentially reducing costs. Many European countries and Canada have accomplished it, but in others, including the United States, significant obstacles still must be overcome.
New data suggests that cancer patients with COVID-19 fare better when treated in urban centers than when managed in population-dense city facilities, regardles of region.
There are no easy answers to the question of whether and how to regionalize care, but a new expert commentary lays out the pros and cons in an illuminating — and sometimes surprising — way.
If all U.S. children who need congenital heart surgery were sent to the nearest high-volume center, they’d have a better chance of survival with only modestly greater travel distance, a modeling study finds.